UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

Journal of clinical oncology, 2009-05, Vol.27 (14), p.2308-2318

2009

Volltextzugriff (PDF)

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study

Journal of clinical oncology, 2016-03, Vol.34 (9), p.910-918

2016

Volltextzugriff (PDF)

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

Cell, 2004-11, Vol.119 (5), p.591-602

2004

Volltextzugriff (PDF)

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Cell, 2004-12, Vol.119 (6), p.861-872

2004

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

The cancer predisposition revolution

Science (American Association for the Advancement of Science), 2016-05, Vol.352 (6289), p.1052-1053

2016

Volltextzugriff (PDF)

Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

Journal of clinical oncology, 2006-02, Vol.24 (6), p.863-871

2006

Volltextzugriff (PDF)

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Clinical cancer research, 2017-06, Vol.23 (11), p.e38-e45

2017

Volltextzugriff (PDF)

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations

PloS one, 2010-05, Vol.5 (5), p.e10813-e10813

2010

Volltextzugriff (PDF)

Clinically relevant changes in family history of cancer over time

JAMA : the journal of the American Medical Association, 2011-07, Vol.306 (2), p.172

2011

Volltextzugriff (PDF)

Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays

PloS one, 2015-03, Vol.10 (3), p.e0116078-e0116078

2015

Volltextzugriff (PDF)

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53

Trends in pharmacological sciences (Regular ed.), 2017-10, Vol.38 (10), p.908-927

2017

Volltextzugriff (PDF)

Activating mutation in MET oncogene in familial colorectal cancer

BMC cancer, 2011-10, Vol.11 (1), p.424-424, Article 424

2011

Volltextzugriff (PDF)

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

Journal of the American Statistical Association, 2019-04, Vol.114 (526), p.541-552

2019

Volltextzugriff (PDF)

Cancer mortality in relatives of desmoid sarcoma patients

Revista Brasileira de Cancerologia, 2023-07, Vol.36 (1/4), p.45-48

2023

Volltextzugriff (PDF)

Assessing BRCA Carrier Probabilities in Extended Families

Journal of clinical oncology, 2006-01, Vol.24 (3), p.354-360

2006

Volltextzugriff (PDF)

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Clinical cancer research, 2017-06, Vol.23 (11), p.e14-e22

2017

Volltextzugriff (PDF)

Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.347-353

2020

Volltextzugriff (PDF)

Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk

Human genetics, 2003-08, Vol.113 (3), p.238-243

2003

Volltextzugriff (PDF)

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome

Biostatistics (Oxford, England), 2020-07, Vol.21 (3), p.467-482

2020

Volltextzugriff (PDF)

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations

Cancer, 2012-02, Vol.118 (4), p.908-913

2012

Volltextzugriff (PDF)

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.354-360

2020

Volltextzugriff (PDF)

Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Cancer epidemiology, biomarkers & prevention, 2005-08, Vol.14 (8), p.1922-1927

2005

Volltextzugriff (PDF)

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.174-183

2011

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Englisch
(203)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

The cancer predisposition revolution

Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations

Clinically relevant changes in family history of cancer over time

Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53

Activating mutation in MET oncogene in familial colorectal cancer

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

Cancer mortality in relatives of desmoid sarcoma patients

Assessing BRCA Carrier Probabilities in Extended Families

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective

Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis

Suchergebnisse filtern